kresmion.

Tango Therapeutics, Inc. (TNGX) relative valueRV

Compared with the rest of its industry group on the figures from its last annual filing.

TNGX's operating margin of -178.4% ranks in the 32nd percentile of 16 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.

Kresmion ranks TNGX against its industry peers from annual SEC filings and market-price snapshots.

As of . Source: SEC EDGAR XBRL company facts. Method and limitations.

Against 24 Biotechnology peers

10-K FY to 31 Dec 2025 in USD
MetricTNGXPeer medianPercentilen
Revenue FY62.4M USD270M USD29th18
Revenue YoYn/an/an/a1
Gross marginn/a67.9%n/a10
Operating margin-178.4%-45.3%32nd16
Net margin-162.9%-39.4%26th16
Return on equity-29.3%-29.1%50th24
P / En/an/an/a3
1 year191.7%-2.6%93rd22

Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Fiscal period ending 2025-12-31. Prices as of 2026-11-16. Every fundamental figure is one full fiscal year from one filing. Nothing is trailing twelve months and nothing is converted between currencies. P/E combines the market-price snapshot with annual earnings; one-year return uses market prices, dated separately above. 0001193125-26-092518

Peer set, 24 companies

LEGN, IRON, VKTX, DYN, IOVA, ELVN, XENE, VRDN, CPRX.D, GRTX.D, ZLAB, TLX, ARQT, DNLI, CELC, CRSP, ACAD, IDYA, VCEL, RLAY, IONS, ADMA, BEAM, DFTX

Left out: PBLS (no annual filing).

What could not be compared

  • 55 The filer did not report this line in the filing used.
  • 22 The denominator is zero or negative, so the ratio has no meaning.
  • 4 The newest price is more than 10 days old.
  • 2 This filer reports an ordinary share count and trades as a depositary receipt at a ratio Kresmion does not store, so price times shares would be wrong.
  • 2 Fewer than 5 peers carry a comparable value, so no median, quartile or percentile is published.
  • 1 The two inputs of this ratio are in different currencies.
  • 1 No annual filing (10-K, 20-F or 40-F) with fiscal-year figures.
  • 1 The latest close times the filed share count disagrees with the company's market cap by more than a split-sized factor, so price and the filing are not on one share basis.

Free account

Open the relative value desk with a free account

An account turns this page into a research desk: thirty-one metrics over the whole peer set instead of eight, the distribution behind each median, the metric's history against the peer band, an editable peer set, and the filing behind every cell. The table above stays free.

Create a free accountSign in

Cite this data

Every fundamental figure is the full fiscal year reported on one annual SEC filing (10-K, 20-F or 40-F), named by accession. Peers are the company's industry group: the GICS sub-industry where the company is GICS-classified, otherwise the data vendor's industry label (the two label sets are not merged). A median, quartile or percentile is published only when at least five peers carry a comparable value, and a peer reporting in another currency is excluded from a level rather than converted. P/E combines the market-price snapshot with annual earnings; one-year return uses market prices, dated separately above.

Upstream: SEC EDGAR XBRL company facts

Kresmion, "TNGX relative value, Kresmion", data as of 2026-03-05, https://kresmion.com/tools/relative-value/TNGX. Upstream data: SEC EDGAR XBRL company facts.

Link to this data (HTML):

<a href="https://kresmion.com/tools/relative-value/TNGX">TNGX relative value, Kresmion (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures